Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy

Advanced Drug Delivery Reviews

Volumn 95, Issue , 2015, Pages 40-49

  Mekaru, Harutaka ^a   Lu, Jie ^a   Tamanoi, Fuyuhiko ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Controlled release; Mesoporous silica nanoparticles; Nanoimpeller; Nanovalve; Oscillating magnetic field; Targeting; Two photon excitation

Indexed keywords

BIODEGRADATION; CHEMICAL MODIFICATION; DISEASES; MAGNETIC FIELDS; MESOPOROUS MATERIALS; NANOMAGNETICS; SILICA NANOPARTICLES; SOLUTIONS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

CONTROLLED RELEASE; MESOPOROUS SILICA NANOPARTICLES; NANOIMPELLER; NANOVALVE; OSCILLATING MAGNETIC FIELDS; TARGETING; TWO-PHOTON EXCITATIONS;

CONTROLLED DRUG DELIVERY;

APTAMER; BETA CYCLODEXTRIN; CAMPTOTHECIN; DENDRIMER; DOXORUBICIN; GOLD NANOPARTICLE; IRON OXIDE; LIPOSOME; MESOPOROUS SILICA NANOPARTICLE; POLYMER; SMALL INTERFERING RNA; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; NANOPARTICLE; SILICON DIOXIDE;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER THERAPY; CHEMICAL MODIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CONJUGATION; CONTROLLED DRUG RELEASE; DISULFIDE BOND; HUMAN; HYDROGEN BOND; LIGHT INTENSITY; MAGNETIC FIELD; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; PH; PHOTOACTIVATION; PRIORITY JOURNAL; THERANOSTIC NANOMEDICINE; ULTRAVIOLET RADIATION; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; NEOPLASMS; POROSITY;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NEOPLASMS; POROSITY; SILICON DIOXIDE;

EID: 84955176021     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.09.009     Document Type: Review

References (97)

1. Estanqueiro M., Amaral M.H., Conceicao J., Sousa Lobo J.M. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf. B: Biointerfaces 2015, 126:631-648.
2. Poon W., Zhang X., Nadeau J. Nanoparticle drug formulations for cancer diagnosis and treatment. Crit. Rev. Oncog. 2014, 19:223-245.
3. Seeta Rama Raju G., Benton L., Pavitra E., Yu J.S. Multifunctional nanoparticles: recent progress in cancer therapeutics. Chem. Commun. (Camb.) 2015, 51:13248-13259.
4. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzym. Regul. 2001, 41:189-207.
5. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
6. Hwang A.A., Lu J., Tamanoi F., Zink J.I. Functional nanovalves on protein-coated nanoparticles for in vitro and in vivo controlled drug delivery. Small 2015, 11:319-328.
7. Ferris D.P., Lu J., Gothard C., Yanes R., Thomas C.R., et al. Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells. Small 2011, 7:1816-1826.
8. Ambrogio M.W., Thomas C.R., Zhao Y.L., Zink J.I., Stoddart J.F. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc. Chem. Res. 2011, 44:903-913.
9. Yaznagisawa T., S T., Kuroda K., Kato C. 56th National Meeting of the Chemical Society of Japan 1988.
10. Inagaki S., Fukushima Y., Kuroda K. Synthesis of highly ordered mesoporous materials from a layered polysilicate. J. Chem. Soc. Chem. Commun. 1993, 680-682.
11. Kresge C.T., Leonowicz M.E., Roth W.J., Vartuli J.C., Beck J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992, 359:710-712.
12. Haffer S., Tiemann M., Froba M. Periodic mesoporous organosilica (PMO) materials with uniform spherical core-shell structure. Chemistry 2010, 16:10447-10452.
13. Hernandez R., Tseng H.R., Wong J.W., Stoddart J.F., Zink J.I. An operational supramolecular nanovalve. J. Am. Chem. Soc. 2004, 126:3370-3371.
14. Xu Z., Liu S., Kang Y., Wang M. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. Nanoscale 2015, 7:5859-5868.
15. Lee C.H., Cheng S.H., Huang I.P., Souris J.S., Yang C.S., et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew. Chem. Int. Ed. 2010, 49:8214-8219.
16. 4 nanoparticles-capped mesoporous silica. Biomaterials 2011, 32:1932-1942.
17. Aznar E., Marcos M.D., Martinez-Manez R., Sancenon F., Soto J., et al. pH- and photo-switched release of guest molecules from mesoporous silica supports. J. Am. Chem. Soc. 2009, 131:6833-6843.
18. Park C., Oh K., Lee S.C., Kim C. Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. Angew. Chem. Int. Ed. 2007, 46:1455-1457.
19. Meng H., Xue M., Xia T., Zhao Y.L., Tamanoi F., et al. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J. Am. Chem. Soc. 2010, 132:12690-12697.
20. Zhao Y.L., Li Z.X., Kabehie S., Botros Y.Y., Stoddart J.F., et al. pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. J. Am. Chem. Soc. 2010, 132:13016-13025.
21. Gao C.B., Zheng H.Q., Xing L., Shu M.H., Che S.N. Designable coordination bonding in mesopores as a ph-responsive release system. Chem. Mater. 2010, 22:5437-5444.
22. Popat A., Liu J., Lu G.Q., Qiao S.Z. A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J. Mater. Chem. 2012, 22:11173-11178.
23. Chen F., Zhu Y.C. Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range. Microporous Mesoporous Mater. 2012, 150:83-89.
24. Ashley C.E., Carnes E.C., Phillips G.K., Padilla D., Durfee P.N., et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 2011, 10:389-397.
25. Lai C.Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 2003, 125:4451-4459.
26. Giri S., Trewyn B.G., Stellmaker M.P., Lin V.S.Y. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew. Chem. Int. Ed. 2005, 44:5038-5044.
27. Slowing I.I., Trewyn B.G., Giri S., Lin V.S.Y. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv. Funct. Mater. 2007, 17:1225-1236.
28. Cui Y.N., Dong H.Q., Cai X.J., Wang D.P., Li Y.Y. Mesoporous silica nanoparticles capped with disulfide-linked peg gatekeepers for glutathione-mediated controlled release. ACS Appl. Mater. Interfaces 2012, 4:3177-3183.
29. Zhang Q., Liu F., Nguyen K.T., Ma X., Wang X.J., et al. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery. Adv. Funct. Mater. 2012, 22:5144-5156.
30. Kim H., Kim S., Park C., Lee H., Park H.J., et al. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv. Mater. 2010, 22. (4280-+).
31. Liu R., Zhao X., Wu T., Feng P.Y. Tunable redox-responsive hybrid nanogated ensembles. J. Am. Chem. Soc. 2008, 130. (14418-+).
32. Zhu C.L., Song X.Y., Zhou W.H., Yang H.H., Wen Y.H., et al. An efficient cell-targeting and intracellular controlled-release drug delivery system based on MSN-PEM-aptamer conjugates. J. Mater. Chem. 2009, 19:7765-7770.
33. Luo Z., Cai K.Y., Hu Y., Zhao L., Liu P., et al. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery. Angew. Chem. Int. Ed. 2011, 50:640-643.
34. Ambrogio M.W., Pecorelli T.A., Patel K., Khashab N.M., Trabolsi A., et al. Snap-top nanocarriers. Org. Lett. 2010, 12:3304-3307.
35. Climent E., Bernardos A., Martinez-Manez R., Maquieira A., Marcos M.D., et al. Controlled delivery systems using antibody-capped mesoporous nanocontainers. J. Am. Chem. Soc. 2009, 131:14075-14080.
36. Aznar E., Coll C., Marcos M.D., Martinez-Manez R., Sancenon M., et al. Borate-driven gatelike scaffolding using mesoporous materials functionalised with saccharides. Chem. Eur. J. 2009, 15:6877-6888.
37. He X.X., Zhao Y.X., He D.G., Wang K.M., Xu F.Z., et al. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles (vol 28, pg 12909, 2012). Langmuir 2013, 29. (510-510).
38. Liu J.J., Zhang B.L., Luo Z., Ding X.W., Li J.H., et al. Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Nanoscale 2015, 7:3614-3626.
39. Bernardos A., Mondragon L., Aznar E., Marcos M.D., Martinez-Manez R., et al. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides". ACS Nano 2010, 4:6353-6368.
40. Mondragon L., Mas N., Ferragud V., de la Torre C., Agostini A., et al. Enzyme-responsive intracellular- controlled release using silica mesoporous nanoparticles capped with e-Poly-l-lysine. Chem. Eur. J. 2014, 20:5271-5281.
41. Ferris D.P., Zhao Y.L., Khashab N.M., Khatib H.A., Stoddart J.F., et al. Light-operated mechanized nanoparticles. J. Am. Chem. Soc. 2009, 131. (1686-+).
42. Yuan Q., Zhang Y.F., Chen T., Lu D.Q., Zhao Z.L., et al. Photon-manipulated drug release from a mesoporous nanocontainer controlled by azobenzene-modified nucleic acid. ACS Nano 2012, 6:6337-6344.
43. Dong J., Zink J.I. Light or heat? the origin of cargo release from nanoimpeller particles containing upconversion nanocrystals under ir irradiation. Small 2015, 11:4165-4172.
44. Lu J., Choi E., Tamanoi F., Zink J.I. Light-activated nanoimpeller-controlled drug release in cancer cells. Small 2008, 4:421-426.
45. Guardado-Alvarez T.M., Devi L.S., Russell M.M., Schwartz B.J., Zink J.I. Activation of snap-top capped mesoporous silica nanocontainers using two near-infrared photons (vol 135, pg 14000, 2013). J. Am. Chem. Soc. 2013, Vol. 135. (17652-17652).
46. Gary-Bobo M., Mir Y., Rouxel C., Brevet D., Hocine O., et al. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: drug delivery, one and two-photon photodynamic therapy. Int. J. Pharm. 2012, 432:99-104.
47. Lin Q.N., Huang Q., Li C.Y., Bao C.Y., Liu Z.Z., et al. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process. J. Am. Chem. Soc. 2010, 132:10645-10647.
48. Croissant J., Zink J.I. Nanovalve-controlled cargo release activated by plasmonic heating. J. Am. Chem. Soc. 2012, 134:7628-7631.
49. Liu H.Y., Chen D., Li L.L., Liu T.L., Tan L.F., et al. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew. Chem. Int. Ed. 2011, 50:891-895.
50. Fang W.J., Yang J., Gong J.W., Zheng N.F. Photo- and pH-triggered release of anticancer drugs from mesoporous silica-coated PdAg nanoparticles. Adv. Funct. Mater. 2012, 22:842-848.
51. Schlossbauer A., Sauer A.M., Cauda V., Schmidt A., Engelke H., et al. Cascaded photoinduced drug delivery to cells from multifunctional core-shell mesoporous silica. Adv. Healthcare Mater. 2012, 1:316-320.
52. Zhang L., Li Y.C., Jin Z.X., Yu J.C., Chan K.M. An NIR-triggered and thermally responsive drug delivery platform through DNA/copper sulfide gates. Nanoscale 2015, 7:12614-12624.
53. Saint-Cricq P., Deshayes S., Zink J.I., Kasko A.M. Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core-shell mesoporous silica nanoparticles. Nanoscale 2015, 7:13168-13172.
54. 4-capped mesoporous silica nanoparticles for intracellular controlled release and MR imaging. J. Mater. Chem. 2011, 21:2535-2543.
55. Lee J.E., Lee N., Kim H., Kim J., Choi S.H., et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J. Am. Chem. Soc. 2010, 132:552-557.
56. Chen Y., Chen H.R., Zeng D.P., Tian Y.B., Chen F., et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano 2010, 4:6001-6013.
57. 3: Preparation and potential application in drug delivery. J. Phys. Chem. C 2008, 112:1851-1856.
58. Baeza A., Guisasola E., Ruiz-Hernandez E., Vallet-Regi M. Magnetically triggered multidrug release by hybrid mesoporous silica nanoparticles. Chem. Mater. 2012, 24:517-524.
59. Thomas C.R., Ferris D.P., Lee J.-H., Choi E., Cho M.H., et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 2010, 132:10623-10625.
60. Lee S.F., Zhu X.M., Wang Y.X., Xuan S.H., You Q., et al. Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems. ACS Appl. Mater. Interfaces 2013, 5:1566-1574.
61. Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3:1341-1346.
62. Song N., Yang Y.W. Molecular and supramolecular switches on mesoporous silica nanoparticles. Chem. Soc. Rev. 2015, 44:3474-3504.
63. Theron C., Gallud A., Carcel C., Gary-Bobo M., Maynadier M., et al. Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding caps as an autonomous drug-delivery system. Chemistry 2014, 20:9372-9380.
64. Dong J., Xue M., Zink J.I. Functioning of nanovalves on polymer coated mesoporous silica nanoparticles. Nanoscale 2013, 5:10300-10306.
65. Tarn D., Ferris D.P., Barnes J.C., Ambrogio M.W., Stoddart J.F., et al. A reversible light-operated nanovalve on mesoporous silica nanoparticles. Nanoscale 2014, 6:3335-3343.
66. Croissant J., Maynadier M., Gallud A., Peindy N.,Dongo H., Nyalosaso J.L., et al. Two-photon-triggered drug delivery in cancer cells using nanoimpellers. Angew. Chem. Int. Ed. 2013, 52:13813-13817.
67. Croissant J., Chaix A., Mongin O., Wang M., Clement S., et al. Two-photon-triggered drug delivery via fluorescent nanovalves. Small 2014, 10:1752-1755.
68. Dong J., Zink J.I. Taking the temperature of the interiors of magnetically heated nanoparticles. ACS Nano 2014, 8:5199-5207.
69. Hom C., Lu J., Liong M., Luo H., Li Z., et al. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small 2010, 6:1185-1190.
70. Finlay J., Roberts C.M., Dong J., Zink J.I., Tamanoi F., et al. Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden. Nanomedicine 2015, 11:1657-1666.
71. Sahu N.K., Singh N.S., Pradhan L., Bahadur D. Ce(3)(+) sensitized GdPO(4):Tb(3)(+) with iron oxide nanoparticles: a potential biphasic system for cancer theranostics. Dalton Trans. 2014, 43:11728-11738.
72. Ke H., Yue X., Wang J., Xing S., Zhang Q., et al. Gold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound/CT imaging and photothermal therapy of cancer. Small 2014, 10:1220-1227.
73. Ma M., Chen H., Chen Y., Wang X., Chen F., et al. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging. Biomaterials 2012, 33:989-998.
74. Sherlock S.P., Tabakman S.M., Xie L., Dai H. Photothermally enhanced drug delivery by ultrasmall multifunctional FeCo/graphitic shell nanocrystals. ACS Nano 2011, 5:1505-1512.
75. Yang D., Dai Y., Liu J., Zhou Y., Chen Y., et al. Ultra-small BaGdF5-based upconversion nanoparticles as drug carriers and multimodal imaging probes. Biomaterials 2014, 35:2011-2023.
76. Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
77. Asefa T., Tao Z. Biocompatibility of mesoporous silica nanoparticles. Chem. Res. Toxicol. 2012, 25:2265-2284.
78. Ekkapongpisit M., Giovia A., Follo C., Caputo G., Isidoro C. Biocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups. Int. J. Nanomedicine 2012, 7:4147-4158.
79. Chen Y., Chen H., Shi J. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles. Adv. Mater. 2013, 25:3144-3176.
80. Yu T., Greish K., McGill L.D., Ray A., Ghandehari H. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. ACS Nano 2012, 6:2289-2301.
81. Yu T., Hubbard D., Ray A., Ghandehari H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J. Control. Release 2012, 163:46-54.
82. Lu J., Li Z., Zink J.I., Tamanoi F. In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification. Nanomedicine 2012, 8:212-220.
83. Souris J.S., Lee C.H., Cheng S.H., Chen C.T., Yang C.S., et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials 2010, 31:5564-5574.
84. He Q., Zhang Z., Gao F., Li Y., Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011, 7:271-280.
85. He Q., Zhang Z., Gao Y., Shi J., Li Y. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. Small 2009, 5:2722-2729.
86. Kempen P.J., Greasley S., Parker K.A., Campbell J.L., Chang H.Y., et al. Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells. Theranostics 2015, 5:631-642.
87. Croissant J., Cattoen X., Man M.W., Gallud A., Raehm L., et al. Biodegradable ethylene-bis(propyl)disulfide-based periodic mesoporous organosilica nanorods and nanospheres for efficient in-vitro drug delivery. Adv. Mater. 2014, 26:6174-6180.
88. Topete A., Alatorre-Meda M., Iglesias P., Villar-Alvarez E.M., Barbosa S., et al. Fluorescent drug-loaded, polymeric-based, branched gold nanoshells for localized multimodal therapy and imaging of tumoral cells. ACS Nano 2014, 8:2725-2738.
89. Lin L.S., Cong Z.X., Cao J.B., Ke K.M., Peng Q.L., et al. Multifunctional Fe(3)O(4)polydopamine core-shell nanocomposites for intracellular mRNA detection and imaging-guided photothermal therapy. ACS Nano 2014, 8:3876-3883.
90. Tian Q., Wang Q., Yao K.X., Teng B., Zhang J., et al. Multifunctional polypyrroleFe(3)O(4) nanoparticles for dual-modal imaging and in vivo photothermal cancer therapy. Small 2014, 10:1063-1068.
91. Chen H., Qi B., Moore T., Wang F., Colvin D.C., et al. Multifunctional yolk-in-shell nanoparticles for pH-triggered drug release and imaging. Small 2014, 10:3364-3370.
92. Mohamed M.S., Veeranarayanan S., Poulose A.C., Nagaoka Y., Minegishi H., et al. Type 1 ribotoxin-curcin conjugated biogenic gold nanoparticles for a multimodal therapeutic approach towards brain cancer. Biochim. Biophys. Acta 2014, 1840:1657-1669.
93. Das M., Mishra D., Dhak P., Gupta S., Maiti T.K., et al. Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging. Small 2009, 5:2883-2893.
94. Santra S., Kaittanis C., Grimm J., Perez J.M. Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. Small 2009, 5:1862-1868.
95. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Control. Release 2009, 138:268-276.
96. Dai Y., Xiao H., Liu J., Yuan Q., Ma P., et al. In vivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles. J. Am. Chem. Soc. 2013, 135:18920-18929.
97. Balasubramanian S., Girija A.R., Nagaoka Y., Iwai S., Suzuki M., et al. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int. J. Nanomedicine 2014, 9:437-459.